© 2017, GENASSIST, Inc.

By Keith S. Wexler, MBA, Maternal Fetal Medicine, Prenatal Diagnosis and Biotech/Life Sciences Consultant, GENASSIST, Inc.

Paul Wexler, M.D., F.A.C.O.G., Medical Director, GENASSIST, Inc.

Clinical Professor, Department of OB/GYN, University of Colorado Health Sciences Center

Clinical Professor, Division of Genetics/Dept. of Pediatrics, Univ. of Colorado/The Children’s Hospital

Reiter’s Syndrome has a usual age of onset of approximately 20-50 years of age. It is more common in males than females. 

Approximately 80% of individuals with the syndrome are HLA B27 compared with only  6-7% of the general population who are HLA B27. 

Reiter’s Syndrome symptoms may be variable with the most frequent symptoms involved being:

  • Joint and/or muscle pain
  • Eyes
  • Skin
  • Mucus membranes
  • Inflammation of the genitourinary tract  

Reiter’s Syndrome treatment may include:

  • Antibiotics
  • Steroids
  • Non Steroidal Anti-Inflammatory Drugs (NSAID’s)

More severe symptoms may require stronger medications including

  • Methotrexate
  • Enbrel (etanercept)
  • Remicade (infliximab)
  • Humira (adalimumab)

Diet modifications and various herbal approaches may offer relief to some patients.